Dengue Tetravalent Vaccine from Germany
A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. Falls under HTS 3002.49.0050 as an 'other' vaccine for human prophylactic use, not matching specific viral listings. Developed through biotechnological recombination.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Secure FDA biologics import authorization; use validated -70°C shipping containers for live virus stability
• Label with serotype composition and expiration; submit CBER lot testing results pre-shipment